Dagny Stuart

Georgia Wiesner, M.D., M.S., has joined Vanderbilt-Ingram Cancer Center (VICC) as professor of Medicine and director of the newly created Clinical and Translational Hereditary Cancer Program. Read More

Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene. Read More

Mammograms can be as easy as TVC. Read More

James Netterville, M.D., professor of Otolaryngology and director of the Head and Neck Surgical Oncology Service, has been elected president of the American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS) and its foundation for the 2012-13 term. He assumed his position in September during the annual meeting in Washington, D.C. Read More

Adult cancer patients and survivors are invited to participate in Vanderbilt-Ingram Cancer Center’s new Thrivership Program, which is designed to restore wellness through physical activity, enhanced nutrition, body awareness and emotional well-being. Read More

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI). Read More

(Vanderbilt University) Members of the Vanderbilt community are invited to lace up their athletic shoes and get ready to race/walk as members of “Team Vanderbilt” at this fall’s cancer awareness events. This year, for the first time, Nashville will host “Purple Strides,” an event sponsored by the… Read More

Stand Up To Cancer (SU2C), the nonprofit organization that helps fund various Vanderbilt-Ingram Cancer Center (VICC) investigators, returns to prime time television for its third broadcast Friday, Sept. 7, at 7 p.m. The hourlong show featuring Hollywood celebrities, recording artists and sports figures will include special performances… Read More

Racial differences exist in quality surgical care, new research from VICC finds. Read More

Vanderbilt-Ingram Cancer Center (VICC) has opened a new outpatient cancer clinic on the NorthCrest Medical Center campus in Springfield, Tenn., to bring high quality care to patients in Middle Tennessee and Southern Kentucky. Read More

Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma. Read More

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation. Read More

Mohamed Hassanein, Ph.D., research instructor in Pulmonary Medicine, has received a Career Development Award from the LUNGevity Foundation to work on the development of noninvasive tests to help diagnose lung cancer. Read More

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. Read More

iStock High consumption of vitamin E either from diet or vitamin supplements may lower the risk of liver cancer, according to a study published July 17 in the Journal of the National Cancer Institute. The study was conducted by investigators from the Shanghai Cancer Institute,… Read More

Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer. Read More

Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer. Read More

Olympic gold medal skating champion and cancer survivor Scott Hamilton was the keynote speaker at Vanderbilt-Ingram Cancer Center’s annual cancer survivors day event held at the Vanderbilt Student Life Center. Nearly 600 people attended “Going for the Gold: Living Well through Cancer,” which featured activities for cancer… Read More

An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma and non-small cell lung cancer. Leora Horn, M.D. Vanderbilt-Ingram Cancer Center investigators Leora Horn, M.D., Jeffrey Sosman, M.D., and researchers from several other cancer… Read More